Recombinant Human CLDN18.2(N-6His,C-Avi)

(No reviews yet) Write a Review
SKU:
RPES6407
Product Type:
Recombinant Protein
Species:
Human

Description

Product Name:Recombinant Human CLDN18.2(N-6His,C-Avi)
Product Code:RPES6407
Size:20µg
Species:Human
Expression Host:E.coli
Synonyms:Claudin-18.2, CLDN18
Mol Mass:12.6 kDa
AP Mol Mass:13 kDa
Tag:N-6His & C-Avi
Purity:> 95 % as determined by reducing SDS-PAGE.
Endotoxin Level:< 1.0 EU per μg of the protein as determined by the LAL method.
Bio Activity:Testing in progress
Accession:P56856-2
Storage:Store at < -20°C, stable for 6 months. Please minimize freeze-thaw cycles.
Shipping:This product is provided as liquid. It is shipped at frozen temperature with blue ice/gel packs. Upon receipt, store it immediately at < - 20°C.
Formulation:Supplied as a 0.2 μm filtered solution of 20mM Tris, 8M Urea,150mM NaCl, 5mM β-ME, pH 8.5. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in
Reconstitution:Not Applicable
Background:Claudin-18(CLDN18) is a protein that in humans is encoded by the CLDN18 gene. It belongs to the group of claudins. CLDN18 belongs to the large claudin family of proteins, which form tight junction strands in epithelial cells. CLDN18 plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity. CLDN18 has two isoform A1 and isoform A2.IMAB362 (Claudiximab) is a monoclonal antibody against isoform 2 of Claudin-18. It is underinvestigation for the treatment of gastrointestinal adenocarcinomas and pancreatic tumors. IMAB362 was developed by Ganymed Pharmaceuticals AG.
View AllClose

0 Reviews

View AllClose

Related Products